|
Pfizer agrees to $430 million neurontin settlement.(Pharmaceutical Sales)
Publication: Medicine & Health Publication Date: 17-MAY-04 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2004 Thomson Financial Inc.
The pharmaceutical giant Pfizer Inc. has agreed to pay $430 million to settle federal and state charges that one of its divisions fraudulently promoted the drug Neurontin for an array of unapproved uses.
In a May 13 statement, the Justice Department said Warner-Lambert Co. used various schemes to encourage physicians to prescribe Neurontin, which was only approved by the Food and Drug Administration as a supplemental anti-seizure medication for epileptics, for ailments including bipolar...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Medicine & Health |
Senate GOP plan: cut red tape, focus on individuals.(Grand Old Party, ...
May 17, 2004
|
Commerce members fault NIH conflict proposals.(Conflicts of Interest)(...
May 17, 2004
|
IRS clarifies HSA interactions with other health accounts.(Internal Re...
May 17, 2004
|
AHA has concerns about proposed inpatient rule.(Hospital Inpatient)(Am...
May 17, 2004
|
Employers plan unified effort on quality, access.(Employer-Sponsored C...
May 17, 2004
|
|
| Find companies classified under Pharmaceutical preparations |
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
